Results 271 to 280 of about 5,018,081 (294)
Some of the next articles are maybe not open access.

Kynurenic acid actions in brain and periphery

International Congress Series, 2007
Abstract. Kynurenic acid (KYNA) is commonly considered a non-competitive NMDA receptor antagonist. It has been recently shown that KYNA also antagonizes the alpha 7 nicotine receptors and reduces glutamate and dopamine release in the rat striatum. Finally, it has been demonstrated that KYNA interacts with GPR35, an orphan receptor negatively coupled ...
MORONI, FLAVIO   +3 more
openaire   +3 more sources

Antagonism of kynurenic acid to anxiogens in mice

Life Sciences, 1998
In a dark-light chamber in mice, kynurenic acid (KYNA, 200 mg/kg, i.p.), an endogenous neuroactive metabolite of tryptophan, attenuated the most stable effect of anxiogens in this model of anxiety--a decrease in the rate of leanings-out of the dark compartment --induced by caffeine, pentylenetetrazole and yohimbine, but not by beta-phenylethylamine ...
openaire   +3 more sources

Quinolinic Acid and Kynurenic Acid in the Mammalian Brain

1991
Over the last decade, the study of neuroexcitatory amino acids has become one of the most rapidly expanding areas of neuroscientific research. Interest in this class of compounds was precipitated mainly by the realization that metabolites such as glutamate and aspartate are major neurotransmitters in the central nervous system (Fonnum, 1984; Erecinska ...
F. Du, Robert Schwarcz
openaire   +3 more sources

KYNURENIC ACID — II. PHOTOSENSITIZING PROPERTIES

Photochemistry and Photobiology, 1979
Abstract— The photosensitizing properties of kynurenic acid have been studied by 353 nm laser flash spectroscopy and steady state irradiations. Laser flash spectroscopy indicates that the kynurenic acid triplet is reduced by amino acids and nucleic acid bases. Photoreactions implying singlet oxygen formation are shown to occur.
Michel Giraud   +2 more
openaire   +2 more sources

Synthesis of New Substituted Kynurenic Acids

Organic Preparations and Procedures International, 2017
Kynurenic acid (4-hydroxyquinoline-2-carboxylic acid) and its derivatives play a crucial role in maintaining normal brain function.1 Several kynurenic acid derivatives containing halo, amino, hydro...
Ajoy K. Banerjee, William J. Vera
openaire   +2 more sources

Production of Quinolinic Acid and Kynurenic Acid by Human Glioma

1991
Using biochemical and immunohistochemical techniques, the biosynthesis of the excitotoxin quinolinic acid (QUIN) and the anti-excitotoxin kynurenic acid (KYNA) in the rat brain has been demonstrated to take place preferentially in glial cells (see Schwarcz and Du, this volume, for review). Although a dysfunction of either of these two brain metabolites
Vezzani, A   +3 more
openaire   +4 more sources

Developmental changes in brain kynurenic acid concentrations

Developmental Brain Research, 1992
The cerebral distribution and regulation of excitatory amino acid levels may play a crucial role in neuronal development. In the present study we examined concentrations of the endogenous excitatory amino acid antagonist kynurenic acid and related substances during development in fetal and neonatal rat brain and fetal non-human primate cerebral cortex.
M. Flint Beal   +2 more
openaire   +3 more sources

Neuroprotective potency of kynurenic acid against excitotoxicity

NeuroReport, 2000
The aim of this study was to determine in vivo which extracellular levels of kynurenic acid (KYNA) are required to control excessive NMDA receptor activation in the rat cortex. As excitotoxicity is coupled to marked ion movements, local depolarisations induced by perfusion of NMDA or quinolinic acid (QUIN) through microdialysis probes were recorded at ...
Jutta Urenjak, Tihomir P. Obrenovitch
openaire   +2 more sources

Tautomeric polymorphism of the neuroactive inhibitor kynurenic acid

Acta Crystallographica Section C Structural Chemistry, 2019
Kynurenic acid (KYN; systematic name: 4-hydroxyquinoline-2-carboxylic acid, C10H7NO3) displays a therapeutic effect in the treatment of some neurological diseases and is used as a broad-spectrum neuroprotective agent. However, it is understudied with respect to its solid-state chemistry and only one crystal form (α-KYN·H2O) has been reported up to now.
Jan Janczak   +4 more
openaire   +3 more sources

Simultaneous determination of tryptophan, kynurenine, kynurenic acid, xanthurenic acid and 5-hydroxytryptamine in human plasma by LC-MS/MS and its application to acute myocardial infarction monitoring.

Biomedical chromotography, 2018
Reliable methods for the determination of tryptophan and its metabolites are vital to the monitoring of biochemical states during the initiation and progression of cardiovascular disease.
Q. Tong   +5 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy